New England Journal of Medicine

Papers
(The TQCC of New England Journal of Medicine is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Clinical Characteristics of Coronavirus Disease 2019 in China19469
A Novel Coronavirus from Patients with Pneumonia in China, 201919330
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine10742
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia10536
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine7308
Dexamethasone in Hospitalized Patients with Covid-196464
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-16418
Remdesivir for the Treatment of Covid-19 — Final Report5126
First Case of 2019 Novel Coronavirus in the United States4200
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-194073
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients3724
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-193524
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma3457
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany2931
Mental Health and the Covid-19 Pandemic2867
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure2569
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2506
Dapagliflozin in Patients with Chronic Kidney Disease2330
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant2196
Fair Allocation of Scarce Medical Resources in the Time of Covid-192047
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting2041
Virtually Perfect? Telemedicine for Covid-192031
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates1977
Empagliflozin in Heart Failure with a Preserved Ejection Fraction1935
Neurologic Features in Severe SARS-CoV-2 Infection1911
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-191846
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series1840
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents1831
Compassionate Use of Remdesivir for Patients with Severe Covid-191817
Cytokine Storm1786
SARS-CoV-2 Infection in Children1735
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility1693
Clinical Characteristics of Covid-19 in New York City1659
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination1649
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial1647
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results1643
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-191627
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young1572
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-191555
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant1535
Multiorgan and Renal Tropism of SARS-CoV-21406
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer1399
Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic1392
Pembrolizumab for Early Triple-Negative Breast Cancer1387
Initial Invasive or Conservative Strategy for Stable Coronary Disease1386
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-191382
Genomewide Association Study of Severe Covid-19 with Respiratory Failure1339
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months1323
Hospitalization and Mortality among Black Patients and White Patients with Covid-191323
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia1273
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-191245
Covid-19 — Navigating the Uncharted1231
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-191221
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-191211
Once-Weekly Semaglutide in Adults with Overweight or Obesity1209
Olaparib for Metastatic Castration-Resistant Prostate Cancer1203
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-191199
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors1175
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients1133
Monkeypox Virus Infection in Humans across 16 Countries — April–June 20221115
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults1110
Developing Covid-19 Vaccines at Pandemic Speed1101
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race1096
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers1076
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination1071
Severe Covid-191051
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes1043
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer1042
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma1030
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-191025
Efficacy of Tocilizumab in Patients Hospitalized with Covid-191015
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure1008
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host1008
Remdesivir for 5 or 10 Days in Patients with Severe Covid-191007
Multisystem Inflammatory Syndrome in Children in New York State1001
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington998
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma996
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months989
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant984
Mild or Moderate Covid-19979
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation975
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment962
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19962
Spread of SARS-CoV-2 in the Icelandic Population956
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer949
Guillain–Barré Syndrome Associated with SARS-CoV-2945
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors941
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia939
Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer928
Colchicine in Patients with Chronic Coronary Disease918
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine916
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine897
Lecanemab in Early Alzheimer’s Disease887
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms886
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates876
Defining the Epidemiology of Covid-19 — Studies Needed876
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma876
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19871
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma868
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes866
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC860
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia850
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel849
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19844
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19839
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19838
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19828
Endometriosis818
The Effect of Advances in Lung-Cancer Treatment on Population Mortality809
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants798
Waning Immunity after the BNT162b2 Vaccine in Israel779
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy770
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam763
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery762
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab762
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2761
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer760
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19760
How Structural Racism Works — Racist Policies as a Root Cause of U.S. Racial Health Inequities759
Sotorasib for Lung Cancers with KRAS p.G12C Mutation758
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis755
Humoral Immune Response to SARS-CoV-2 in Iceland754
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer751
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer742
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction738
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma737
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients736
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers732
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination731
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis731
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19721
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer718
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction717
Responding to Covid-19 — A Once-in-a-Century Pandemic?715
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol701
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer699
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients698
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine695
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting690
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia681
Tirzepatide Once Weekly for the Treatment of Obesity680
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents673
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma669
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults669
HPV Vaccination and the Risk of Invasive Cervical Cancer666
Covid-19 and Health Care’s Digital Revolution664
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia650
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications648
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile644
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19643
Neuropathological Features of Covid-19632
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons624
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer620
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar618
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine615
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease609
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer609
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination607
Covid-19 and Kidney Transplantation604
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment601
Vaccine Breakthrough Infections with SARS-CoV-2 Variants600
Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line594
Another Decade, Another Coronavirus592
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes592
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19591
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis581
Trial of Psilocybin versus Escitalopram for Depression577
Autophagy in Human Diseases575
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19573
Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report570
Donanemab in Early Alzheimer’s Disease570
ST-Segment Elevation in Patients with Covid-19 — A Case Series565
New-Onset Diabetes in Covid-19558
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes542
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications542
Racial Health Disparities and Covid-19 — Caution and Context537
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer532
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer527
Rivaroxaban in Peripheral Artery Disease after Revascularization526
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa524
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer523
The Untold Toll — The Pandemic’s Effects on Patients without Covid-19521
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma519
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease519
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction509
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke508
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis503
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19498
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant498
Neutralizing Activity of BNT162b2-Elicited Serum493
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy493
Children with Covid-19 in Pediatric Emergency Departments in Italy484
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest483
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing483
The Toughest Triage — Allocating Ventilators in a Pandemic483
Racial Bias in Pulse Oximetry Measurement482
Capmatinib inMETExon 14–Mutated orMET-Amplified Non–Small-Cell Lung Cancer481
Pathophysiology of Inflammatory Bowel Diseases477
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China475
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women473
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis472
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement470
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines467
Empagliflozin in Patients with Chronic Kidney Disease465
Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI463
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis463
Covid-19 — Implications for the Health Care System456
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China449
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes448
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations447
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer442
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients438
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer436
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization436
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine431
Acquired Resistance to KRASG12C Inhibition in Cancer430
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia428
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma427
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer426
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19424
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis419
Avacopan for the Treatment of ANCA-Associated Vasculitis418
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19416
Transmission of SARS-CoV-2 in Domestic Cats413
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection410
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers410
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation409
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19408
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma406
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel406
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine403
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China402
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis402
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer400
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease399
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer398
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5393
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age389
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer387
Homologous and Heterologous Covid-19 Booster Vaccinations383
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19382
Barrier Enclosure during Endotracheal Intubation382
Structural Racism, Social Risk Factors, and Covid-19 — A Dangerous Convergence for Black Americans381
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma380
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation379
Microvascular Injury in the Brains of Patients with Covid-19377
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase374
Evinacumab for Homozygous Familial Hypercholesterolemia373
A Population-Based Study of Genes Previously Implicated in Breast Cancer371
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia370
0.050295829772949